Agilent Technologies Inc. has announced the acquisition of e-MSion, an early-stage company behind the innovative electron capture dissociation technology known as the ExD cell.

SonALAsense has announced that the first cohort in Sonodynamic Therapy (SDT)-202 was fully enrolled.

Antiverse Ltd has announced the successful identification of functional antibody clusters targeting two G-protein-coupled receptors, both displaying versatile binding profiles and nanomolar affinity.

Terebellum, subsidiary of global specialty pharmacy and healthcare solutions organization AscellaHealth, is launching a strategic guide to help manufacturers bring rare disease products to market.

Carterra Inc. launched its latest HT-SPR instrument, the LSAXT, at the Society for Laboratory Automation and Screening (SLAS) Conference and Exhibition in San Diego, CA.

CN Bio has announced the commercial launch of the PhysioMimix™ Single-organ Higher Throughput System.

Agilent Technologies Inc. will highlight a suite of automated laboratory workflow solutions at the SLAS2023 International Conference and Exhibition held February 25 through March 1 in San Diego.

Akamis Bio has announced an expansion of its ongoing partnership with the Parker Institute for Cancer Immunotherapy to include a clinical collaboration with the Cancer Research Institute that will focus on advancing novel treatments for pancreatic cancer.

Particle Works is making major contributions to the field of nanomedicine by producing automated microfluidic systems with the potential to improve efficiency in the nanotherapeutic drug development pipeline.

Insilico Medicine has announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to INS018_055 for the treatment of idiopathic pulmonary fibrosis.